Zobrazeno 1 - 10
of 160
pro vyhledávání: '"Michele, Ghielmini"'
Publikováno v:
BMC Pharmacology and Toxicology, Vol 21, Iss 1, Pp 1-7 (2020)
Abstract Background After several decades, cisplatin continues to be an essential drug for the treatment of several tumors, however, its potential nephrotoxicity is still a clinically relevant issue. Identification of predisposing factors for renal t
Externí odkaz:
https://doaj.org/article/5bac10a54abe4a03974ca88ca0090164
Publikováno v:
HemaSphere, Vol 4, Iss 1, p e317 (2020)
Abstract. The overall prognosis of patients with follicular lymphoma has substantially improved over the last decades with a 10-year overall survival of around 80% for the majority of patients. However, for most patients follicular lymphoma it is sti
Externí odkaz:
https://doaj.org/article/ecb51e2187cd4511b4f535431ea7aa92
Autor:
Veronika Ballova, Barbara Muoio, Domenico Albano, Francesco Bertagna, Luca Canziani, Michele Ghielmini, Luca Ceriani, Giorgio Treglia
Publikováno v:
Diagnostics, Vol 10, Iss 2, p 101 (2020)
Background: Some studies evaluated the diagnostic performance of fluorine-18-fluorodeoxyglucose (18F-FDG) positron emission tomography or positron emission tomography/computed tomography (PET or PET/CT) for the detection of post-transplant lymphoprol
Externí odkaz:
https://doaj.org/article/884e3ee157a947ca84c33f2197c0bc30
Autor:
Liat Vidal, Anat Gafter-Gvili, Martin Dreyling, Michele Ghielmini, Mathias Witzens-Harig, Ofer Shpilberg, Michael Unterhalt, Mathias Rummel, Ronit Gurion
Publikováno v:
HemaSphere, Vol 2, Iss 4 (2018)
Abstract. Current treatment of patient with mantle cell lymphoma (MCL) is insufficient and does not result in cure. To assess the efficacy and safety of maintenance therapy for patients with MCL, we performed a systematic review and meta-analysis of
Externí odkaz:
https://doaj.org/article/47248c88673542ec87f55becdcc24b67
Autor:
Bernhard Gerber, Martina Manzoni, Valeria Spina, Alessio Bruscaggin, Marta Lionetti, Sonia Fabris, Marzia Barbieri, Gabriella Ciceri, Alessandra Pompa, Gabriela Forestieri, Erika Lerch, Paolo Servida, Francesco Bertoni, Emanuele Zucca, Michele Ghielmini, Agostino Cortelezzi, Franco Cavalli, Georg Stussi, Luca Baldini, Davide Rossi, Antonino Neri
Publikováno v:
Haematologica, Vol 103, Iss 6 (2018)
Externí odkaz:
https://doaj.org/article/cac49ae32fee42aa814cbe7b70af622f
Autor:
Jesse G. Dixon, Çağlar Çağlayan, Dai Chihara, Tina Nielsen, Natalie Dimier, Jamie Zheng, Anna K. Wall, Gilles Salles, Franck Morschhauser, Robert Marcus, Michael Herold, Eva Kimby, Kristie A. Blum, Michele Ghielmini, Qian Shi, Christopher R. Flowers
Publikováno v:
Clinical lymphoma, myelomaleukemia. 22(11)
Leveraging the Follicular Lymphoma Analysis of Surrogacy Hypothesis database of individual patient data from first-line clinical trials, we studied the clinical course of follicular lymphoma (FL) and investigated clinical factors associated with FL o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17980184b294c49a394ba65721061987
https://pubmed.ncbi.nlm.nih.gov/36045021
https://pubmed.ncbi.nlm.nih.gov/36045021
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 8, Iss 0, Pp e2016062-e2016062 (2016)
The natural history of follicular lymphoma is usually characterized by an indolent course with a high response rate to the first line therapy followed by recurrent relapses, with a time to next treatment becoming shorter after each subsequent treatme
Externí odkaz:
https://doaj.org/article/732860f82c7e4ee78973c62b54825d6b
Autor:
Emanuele Zucca, Christian Taverna, Michele Ghielmini, Stefanie Hayoz, Alden A. Moccia, Eva Kimby, Urban Novak, Sämi Schär, Maria Cristina Pirosa
Publikováno v:
British Journal of Haematology. 192:1031-1034
The relapse of follicular lymphoma (FL) within 24 months (POD24) of chemoimmunotherapy has been associated with poor survival. We analyzed a pooled dataset of three randomized trials including FL patients with advanced disease, conducted by the Swiss
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac00c53f96fd1f870578685e04aa43a5
https://doi.org/10.1111/bjh.17045
https://doi.org/10.1111/bjh.17045
Publikováno v:
BMC Pharmacology and Toxicology, Vol 21, Iss 1, Pp 1-7 (2020)
BMC Pharmacology & Toxicology
BMC Pharmacology & Toxicology
Background After several decades, cisplatin continues to be an essential drug for the treatment of several tumors, however, its potential nephrotoxicity is still a clinically relevant issue. Identification of predisposing factors for renal toxicity c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc6a6d6bb110c78f04be7b18c8ea5635
http://link.springer.com/article/10.1186/s40360-020-0398-3
http://link.springer.com/article/10.1186/s40360-020-0398-3
Autor:
Werner Kempf, Anne-Katrin Zimmermann, Michele Ghielmini, Arbeneshe Berisha, Andreas Zettl, Rocco Torricelli
Publikováno v:
The American Journal of Dermatopathology. 41:602-605
Large B-cell lymphomas include several subtypes. Recently, anaplastic lymphoma kinase (ALK)-positive large B-cell lymphoma has been delineated as a distinct entity involving mostly lymph nodes and rarely affecting extranodal sites. We describe the fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb468ff531cf839c4ba9271c0b322cdb
https://doi.org/10.1097/dad.0000000000001348
https://doi.org/10.1097/dad.0000000000001348